Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 3 (2006), Issue 11 (November)

1. Motor learning and Parkinson disease: Refinement of movement velocity and endpoint excursion in a limits of stability balance task.
   Neurorehabil Neural Repair, 20(4): 459-67. [Abstract] [Full-text]
2. Nitric oxide synthase regulation and diversity: implications in Parkinson's disease.
   Nitric Oxide, 15(4): 280-94. [Abstract] [Full-text]
3. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
   Nucl Med Commun, 27(12): 945-51. [Abstract] [Full-text]
4. Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data.
   Nucl Med Commun, 27(12): 939-44. [Abstract] [Full-text]
5. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
   Nucl Med Commun, 27(12): 933-7. [Abstract] [Full-text]
6. In a randomized study of envelope and ink color, colored ink was found to increase the response rate to a postal questionnaire.
   J Clin Epidemiol, 59(12): 1326-30. [Abstract] [Full-text]
7. Elevations in local gamma activity are accompanied by changes in the firing rate and information coding capacity of neurons in the region of the subthalamic nucleus in Parkinson's disease.
   Exp Neurol, 202(2): 271-9. [Abstract] [Full-text]
8. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.
   Neurosci Lett, 410(2): 80-4. [Abstract] [Full-text]
9. A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese.
   Neurosci Lett, 410(2): 121-5. [Abstract] [Full-text]
10. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?
    J Neurol Neurosurg Psychiatry, 77(12): 1363-6. [Abstract] [Full-text]
11. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 77(12): 1323-8. [Abstract] [Full-text]
12. Physical activity and risk of Parkinson's disease: a prospective cohort study.
    J Neurol Neurosurg Psychiatry, 77(12): 1318-22. [Abstract] [Full-text]
13. Ten steps to identify atypical parkinsonism.
    J Neurol Neurosurg Psychiatry, 77(12): 1367-9. [Abstract] [Full-text]
14. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.
    Lancet Neurol, 5(12): 1013-20. [Abstract] [Full-text]
15. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Neurobiol Dis, 25(1): 134-49. [Abstract] [Full-text]
16. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
    Neurobiol Dis, 25(1): 112-20. [Abstract] [Full-text]
17. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
    Eur Neuropsychopharmacol, 17(3): 165-71. [Abstract] [Full-text]
18. Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease.
    Eur Neuropsychopharmacol, 17(3): 206-14. [Abstract] [Full-text]
19. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease.
    Neurology, 67(10): 1781-5. [Abstract] [Full-text]
20. Driving with distraction in Parkinson disease.
    Neurology, 67(10): 1774-80. [Abstract] [Full-text]
21. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Neurology, 67(10): 1786-91. [Abstract] [Full-text]
22. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Brain, 129: 3356-65. [Abstract] [Full-text]
23. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
    Brain, 129: 3366-75. [Abstract] [Full-text]
24. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.
    J Neurosci, 26(48): 12497-511. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.